A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens

PHASE2CompletedINTERVENTIONAL
Enrollment

463

Participants

Timeline

Start Date

March 23, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

August 23, 2021

Conditions
Ovarian NeoplasmsOvarian Cancer
Interventions
DRUG

Niraparib

Trial Locations (55)

10065

GSK Investigational Site, New York

11042

GSK Investigational Site, Lake Success

11432

GSK Investigational Site, Jamaica

11733

GSK Investigational Site, East Setauket

19096

GSK Investigational Site, Wynnewood

21202

GSK Investigational Site, Baltimore

27710

GSK Investigational Site, Durham

30342

GSK Investigational Site, Atlanta

33401

GSK Investigational Site, West Palm Beach

33612

GSK Investigational Site, Tampa

37203

GSK Investigational Site, Nashville

46260

GSK Investigational Site, Indianapolis

48109

GSK Investigational Site, Ann Arbor

54244

GSK Investigational Site, Indianapolis

55455

GSK Investigational Site, Minneapolis

55905

GSK Investigational Site, Rochester

60611

GSK Investigational Site, Chicago

60637

GSK Investigational Site, Chicago

65804

GSK Investigational Site, Springfield

70121

GSK Investigational Site, New Orleans

70433

GSK Investigational Site, Covington

73104

GSK Investigational Site, Oklahoma City

75390

GSK Investigational Site, Dallas

75702

GSK Investigational Site, Tyler

76104

GSK Investigational Site, Fort Worth

77380

GSK Investigational Site, The Woodlands

78229

GSK Investigational Site, San Antonio

78731

GSK Investigational Site, Austin

85016

GSK Investigational Site, Phoenix

85224

GSK Investigational Site, Chandler

85710

GSK Investigational Site, Tucson

90027

GSK Investigational Site, Los Angeles

90048

GSK Investigational Site, Los Angeles

91010

GSK Investigational Site, Duarte

91505

GSK Investigational Site, Burbank

93105

GSK Investigational Site, Santa Barbara

94118

GSK Investigational Site, San Francisco

98405

GSK Investigational Site, Tacoma

99202

GSK Investigational Site, Spokane

94305-5317

GSK Investigational Site, Stanford

06510

GSK Investigational Site, New Haven

02115

GSK Investigational Site, Boston

02215

GSK Investigational Site, Boston

01805

GSK Investigational Site, Burlington

07601

GSK Investigational Site, Hackensack

07962-1956

GSK Investigational Site, Morristown

97504-8342

GSK Investigational Site, Medford

02905

GSK Investigational Site, Providence

T2N 4N2

GSK Investigational Site, Calgary

M5G 2M9

GSK Investigational Site, Toronto

H1T 2M4

GSK Investigational Site, Montreal

H2L 4M1

GSK Investigational Site, Montreal

H3T 1E2

GSK Investigational Site, Montreal

H4A 3J1

GSK Investigational Site, Montreal

J1H 5N4

GSK Investigational Site, Sherbrooke

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Facing Our Risk of Cancer Empowered

OTHER

collaborator

Myriad Genetics, Inc.

INDUSTRY

lead

Tesaro, Inc.

INDUSTRY